Supported by

Tricuspid / Pulmonary valve

Latest tricuspid content in interventional cardiology - research, practice, and education

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

523 results

The PCR Tricuspid Focus Group at EuroPCR 2022

02 Jun 2022

 

During #EuroPCR 2022, Alessandro Sticchi, member of the PCR Tricuspid group, interviewed several speakers on tricuspid interventions.

The PCR Tricuspid Focus Group at EuroPCR 2022

The role and evolution of imaging in tricuspid interventions

18 May 2022 – From EuroPCR 2022

In this interview, João Cavalcante and Alessandro Sticchi discuss the evolving role and evolution of advanced imaging in tricuspid interventions.

The role and evolution of imaging in tricuspid interventions

Evolution and prognostic impact of cardiac damage after aortic valve replacement

24 May 2022

The aim of the current study was to describe and characterize the natural evolution of cardiac damage post-AVR and its outcomes.

Elad Asher

Reviewer

Elad Asher
Evolution and prognostic impact of cardiac damage after aortic valve replacement

EuroPCR 2022 - summaries of late-breaking science, trials and registries in Valvular Interventions and Structural Heart Disease

22 May 2022

Jonathan Curio provides his take on the new data presented at EuroPCR 2022 in Valvular Interventions and Structural Heart Disease by providing summarised key take-aways!

Jonathan Curio

Author

Jonathan Curio
EuroPCR 2022 - LBT summaries

Innovation fireworks

20 May 2022 – From EuroPCR 2022

Find out more about novel innovative techniques and devices including: Leaflex, a possible alternative to balloon valvuloplasty, Valvosoft, a non-invasive ultrasound therapy or even home blood potassium monitoring!

Innovation fireworks

Transcatheter tricuspid valve repair: CLASP TR study one-year results

19 May 2022 – From EuroPCR 2022

Alessandro Sticchi asks Rebecca Hahn about the one-year results of the CLASP TR study and the impact it will have on the management of tricuspid regurgitation.

Transcatheter tricuspid

Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study

20 May 2022 – From EuroPCR 2022

Philip Lurz speaks with Alessandro Sticchi about the 30-day results from the TriClip bRIGHT study on 300 subjects with symptomatic tricuspid regurgitation. He also shares his perspective on the future of edge to edge treatment in the tricuspid field.

Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study

Treating tricuspid regurgitation percutaneously: tools and impacts

19 May 2022 – From EuroPCR 2022

Discover the tools and impacts of treating tricuspid regurgitation percutaneously by watching the cases of valve replacement, valve-in-ring implantation, transcatheter edge-to-edge repair and many more.

Treating tricuspid regurgitation percutaneously: tools and impacts

TriClip therapy: here now, here to stay

19 May 2022 – From EuroPCR 2022

Discover how tricuspid clip dedicated therapy allows treating a broad range of anatomies through real-life cases. Also, learn about its real-world outcomes and the performance in different tricuspid regurgitation patient profiles.

TriClip therapy: here

A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation

19 May 2022 – From EuroPCR 2022

In this session from EuroPCR 2022, the speakers introduce different options available for treating tricuspid regurgitation. They discuss the anatomical considerations that define suitable candidates and review different transcatheter options and their key differentiators.

A patient-focused transcatheter